为心脏性休克提供个性化的机械循环支持:对当前设备的审查和比较
Bradley Fujiuchi1, Kevin Benavente1, Hafeez Ul Hassan Virk2
1Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii, USA.
概括
心脏性休克 (CS) 管理涉及机械循环支持 (MCS) 设备. 对CS患者的最佳时间和设备选择仍然不清楚,需要审查当前的MCS选项以改善结果.
科学领域:
- 心脏病学 心脏病学
- 临界护理医学 临界护理医学
- 医疗器械 医疗器械
背景情况:
- 心脏性休克 (CS) 是一种严重的疾病,死亡率高,经常使急性心肌梗塞 (AMI) 和心力衰竭 (HF) 复杂化.
- 机械循环支持 (MCS) 设备对于CS患者的血液动力稳定性和末端器官输液至关重要.
- 目前的指导方针缺乏关于最佳时机和选择MCS设备的CS管理的清晰度.
研究的目的:
- 审查目前用于心脏性休克 (CS) 的机械循环支持 (MCS) 设备的现状.
- 探索各种MCS设备的证据,关键区别,优势和局限性.
- 为了解决CS的异质性,并指导最佳设备选择,以改善患者的治疗结果.
主要方法:
- 目前用于心脏性休克 (CS) 的机械循环支持 (MCS) 设备的文献综述.
- 分析支持使用不同MCS设备的证据.
- 设备特征,适应症和结果的比较.
主要成果:
- 机械循环支持 (MCS) 设备对于管理心脏性休克 (CS) 是至关重要的,提供血液动力学支持和桥梁恢复或先进疗法.
- 心脏性休克 (CS) 呈现和患者个人资料存在显著的异质性,影响器械选择.
- 对于MCS启动的最佳时间和特定的设备选择标准需要进一步阐明.
结论:
- 了解各种机械循环支持 (MCS) 设备的不同作用和局限性,对于有效的心脏性休克 (CS) 管理至关重要.
- 个性化的患者选择和及时的MCS干预对于改善心脏性休克 (CS) 存活率至关重要.
- 需要进行进一步的研究,以制定明确的指导方针,以便在心脏性休克 (CS) 中选择最佳的MCS设备和时间.
相关概念视频
01:24Blood Pressure Imbalances and Circulatory Shock
1.0K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.0K
01:22Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39
01:29Cardiomyopathy V: Interprofessional Care
41
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
01:30Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30